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Dietary isothiocyanates such as phenethyl isothiocyanate (PEITC)
and allyl isothiocyanate (AITC) have anti-carcinogenic activities
and are of potential use in the chemoprevention of cancer (Hecht,
1995). Chemopreventive activity is associated with inhibition of
the activation of carcinogens by cytochrome P450 isozymes
(Conaway et al, 1996), increased excretion of carcinogens by
quinone reductase and GSH S-transferases (Bogaards et al, 1990;
Zheng et al, 1992), and also induction of apoptosis in pre-clinical
tumours (Nishikawa et al, 1997; Samaha et al, 1997; Sugie et al,
1999). The mechanism of induction of apoptosis is unknown. 
PEITC and AITC inhibited the growth and induced apoptosis
of human leukaemia (HL60) cells in vitro (Adesida et al, 1996;
Xu and Thornalley, 2000). PEITC-induced apoptosis was
characterized by entry of PEITC into cells and rapid formation 
and expulsion of the glutathione adduct S-(N-phenethylthio-
carbamoyl)glutathione (PETC-SG), and protein thiocarbamoyla-
tion – exacerbated by the decrease in cellular glutathione (Xu and
Thornalley, 2001). This committed the cells to apoptosis with a
critical activation of caspase-8 in the initial 3 h and later activation
of caspase-3 (Xu and Thornalley, 2000). The specific caspase-8
inhibitor Z-IETD-fmk, the general caspase inhibitor Z-VAD-fmk
and a high concentration of glutathione (15 mM) inhibited PEITC-
induced apoptosis completely (Xu and Thornalley, 2001). PEITC
was found to induce a sustained activation of JNK1 in HeLa cells
(Yu et al, 1996) and Jurkat cells in vitro (Chen et al, 1998). This
was associated with activation of MEKK1 (Chen et al, 1998).
Overexpression of Bcl-2 and Bcl-xL suppressed both PEITC-
induced activation of JNK1 and apoptosis, suggesting that Bcl-2
and Bcl-xL could intervene upstream of JNK1 activation in
PEITC-induced apoptosis (Chen et al, 1998). Curcumin is an
inhibitor of JNK signalling upstream of MEKK1 (Chen and Tan,
1998) and it delayed the induction of apoptosis by PEITC (Xu and
Thornalley, 2001). 
Recent investigations of caspase-8 activated apoptosis have
suggested a critical role of cleavage of the cytosolic protein BID
(Bossy-Wetzel and Green, 1999; Gross et al, 1999) and a role
for caspases in the activation of MEKK1 in the JNK pathway
(Cardone et al, 1997). Protein tyrosine phosphorylation and inhibi-
tion of protein tyrosine phosphatase activity has been associated
with apoptosis where JNK activation was involved (Lumelsky and
Schwartz, 1996; Chen et al, 1999). Potent thiol-modifying agents
such as isothiocyanates may induce apoptosis by inhibiting protein
tyrosine phosphatase activity (Denu and Tanner, 1998). Our recent
work has indicated that peptide and protein thiol modification by
isothiocyanates may play a critical role in activating apoptosis. We
describe here, for the first time, experiments designed to examine
these features of isothiocyanate-induced apoptosis. 
MATERIALS AND METHODS 
Chemicals 
PEITC and AITC were purchased from Aldrich Chemical Co 
Ltd (Poole, UK). The caspase inhibitor N-benzyloxycarbonyl-
Val-Ala-Asp(OMe)-fluoromethylketone (Z-VAD-FMK) was pur-
chased from Calbiochem (Nottingham, UK). [g-33P]Adenosine 5¢-
triphosphate was purchased from NEN Life Science Products, Inc
(Stevenage, UK). Mouse monoclonal anti-phosphotyrosine IgG
antibody (clone PT66, ascites fluid), horseradish peroxidase
(HRP)-conjugated goat anti-mouse IgG were purchased from
Sigma Chemical Co Ltd (Poole, UK). Goat polyclonal anti-BID
antibody and HRP-conjugated donkey anti-goat IgG were
purchased from Santa Cruz Biotechnology Inc (Santa Cruz, USA).
Streptavidin-HRP (SAv-HRP) conjugate was purchased from
Pharmingen (San Diego, USA). Biotinylated SDS-PAGE molecu-
lar mass protein standards (6.5–200 kDa) were purchased from
Bio-Rad Laboratories Ltd (Hemel Hempstead, UK). Nitrocellulose
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membranes were purchased from Sartorius Ltd (Epsom, UK).
Enhanced chemiluminescence (ECL) Western blotting reagents
were purchased from Amersham Life Science (Amersham, UK).
Protein tyrosine phosphatase (PTP) assay and JNK kinase assay
kits were purchased from New England BioLabs (Hitchin, UK). 
Cell culture 
HL60 cells were cultured in RPMI 1640 media containing 10%
fetal calf serum under an atmosphere of 5% CO2 in air, 100%
humidity and 37˚C (Adesida et al, 1996). Cells were seeded at
5 ´ 104 ml–1 and incubated with and without 5 or 10 mM PEITC
or AITC, and with and without other agents (15 mM GSH,
50 mM curcumin or 50 mM Z-VAD-fmk). 
Sodium dodecyl sulphate-polyacrylamide 
gel-electrophoresis (SDS-PAGE) 
Electrophoresis was performed with 12% (w/v) SDS-polyacryl-
amide separating gels (80 mm ´ 60 mm ´ 1 mm), similar to the
method described (Allen et al, 1993). Electrophoresis was
performed for 1.5 h at 20 mA constant current. 
Measurement of protein tyrosine phosphorylation 
HL60 cells (5 ´ 105 ml–1, 20 ml) were incubated with and without
isothiocyanates and other agents for the times indicated, washed
twice with ice-cold phosphate-buffered saline (PBS) and the cell
pellets lysed in 50 ml of lysis buffer (1% Nonidet P-40, 137 mM
NaCl, 10% glycerol, 1 mM phenylmethylsulphonyl fluoride, apro-
tinin (0.15 U ml–1), 1 mM Na3 VO4 and 20 mM Tris-HCl, pH 8) for
30 min on ice. Lysates were centrifuged (15 000 g, 20 min, 4˚C).
Two-fold concentrated SDS-sample buffer (217 mM Tris-HCl, pH
6.7; 17.4% glycerol, 5% SDS, 9% 2-mercaptoethanol, 0.0017%
bromophenol blue) was added to cell lysate, boiled for 5 min and
electrophoresed on a 12% SDS-polyacrylamide gel at 20 mA for 
2 h. Biotinylated molecular mass protein standards (6.5–200 kDa)
were run concurrently. Proteins were transferred electrophoretic-
ally to nitrocellulose membranes (35 mA, 1 h). Membranes were
blocked for 1 h at room temperature with 5% milk protein, 0.1%
Tween 20 in PBS (PBS-Tween), rinsed twice followed by three
10 min washes with PBS-Tween. Membranes were probed at room
temperature with monoclonal anti-phosphotyrosine IgG at 1:2000
dilution in PBS-Tween with 3% milk protein for 1 h. After
washing, membranes were probed with HRP-conjugated goat anti-
mouse IgG at 1:10 000 dilution in PBS-Tween with 3% milk
protein for 1 h. Molecular mass standards were probed with 
SAv-HRP at 1:1000 dilution in PBS-Tween with 3% milk protein.
After washing, blots were developed with the ECL detection
system. 
Assay of protein tyrosine phosphatase 
Protein tyrosine phosphatase (PTP) activity was assayed by
measuring the rate of dephosphorylation of tyrosine [33P]phos-
phorylated myelin basic protein (MyBP). [33P]MyBP was prepared
from MyBP with g-[33P]-ATP and Abl protein tyrosine kinase
according to the manufacturer’s instructions (New England
BioLabs), giving a solution of 2.0 mM [33P]MyBP with a tyrosine
phosphorylation of 0.48. The PTP activity of HL60 cell lysates
was determined by incubation of 30 ml of assay buffer (50 mM
Tris-HCl, pH 7.5; 1 mM Na2EDTA, 0.01% Brij 35, 1 mg ml–1
bovine serum albumin), 10 ml of cell lysate, 30 ml of 2.0 mM
[33P]MyBP for 10 min at 30˚C. The reaction was terminated by
addition of 200 ml of 20% TCA. The solution was placed on ice for
5–10 min, centrifuged (12 000 g, 5 min, 4˚C) and 200 ml of super-
natant removed, scintillation cocktail added and counted. The
activity of PTP is given in units where one unit of PTP activity
releases one nmol of phosphate from [33P]MyBP per minute under
assay conditions. 
Measurement of BID and BID fragmentation 
The procedure was similar to the measurement of protein tyrosine
phosphorylation, except that the primary antibody was goat
polyclonal anti-BID antibody, and secondary antibody was
HRP-conjugated donkey anti-goat IgG. 
Assay of JNK activity 
This was performed according to the manufacturer’s protocol
(New England BioLabs). Briefly, after incubations, cell lysates
were prepared, and incubated with c-Jun fusion protein beads
overnight at 4˚C. After centrifugation (15 000 g, 2 min, 4˚C),
pellets were washed twice with 0.5 ml of lysis buffer (20 mM Tris-
HCl, pH 7.4; 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1%
Triton, 2.5 mM sodium pyrophosphate, 1 mM b-glycerolphos-
phate, 1 mM Na3VO4, 1 mgm l –1 leupeptin, 1 mM PMSF), and
twice with 0.5 ml of kinase buffer (25 mM Tris-HCl, pH 7.5; 
5 mM  b-glycerolphosphate, 2 mM DTT, 0.1 mM Na3VO4, 10 mM
MgCl2). The pellet was re-suspended in 50 ml of kinase buffer
supplemented with 100 mM ATP and incubated for 30 min at
30˚C. The reaction was terminated by addition of 50 ml of 2-fold
concentrated SDS-PAGE sample buffer. Samples were boiled for 
5 min, cooled and centrifuged (10 000 g, 2 min, 4˚C), and loaded
onto a 12% SDS-PAGE gel. SDS-PAGE, electrophoretic transfer
to nitrocellulose with blocking by 2% (w/v) milk protein, and
Western blotting with primary antibody (rabbit anti-phospho-c-
Jun antibody, 1:1000 dilution) and secondary antibody (HRP-
conjugated anti-rabbit antibody, 1:2000 dilution) were performed.
Proteins were detected with the ECL detection system. 
RESULTS 
The pro-apoptotic protein BID, when processed by caspase-8 and
caspase-3 to the truncated form tBID, is a major initiator of mito-
chondrial dysfunction in apoptosis. When HL60 cell cytosolic
extracts were blotted with anti-BID IgG, full-length BID protein of
molecular mass 22 kDa was detected, with non-specific blotting of
protein bands of >30 kDa (Figure 1A, lane 1). When HL60 cells
were incubated with 10 mM PEITC for 6 h, cytosolic extracts indi-
cated a loss of full-length BID and the appearance of fragments of
molecular mass at 15, 13 and 11 kDa (Figure 1A, lane 2). This
fragmentation was prevented by the addition of 15 mM GSH
(Figure 1A, lanes 3 and 4). 
PEITC and AITC activated JNK activity in HL60 cells. AITC
was a stronger inducer of JNK activity than PEITC although AITC
was slightly less cytotoxic (Xu and Thornalley, 2000) – the TC50
values of PEITC and AITC were 4.95 mM and 11.0 mM, respect-
ively. The induction of JNK activity was prevented by 15 mM
GSH (Figure 2A). During PEITC-induced apoptosis, the activity of
JNK was high after 3 h and decreased at 6 h and 9 h (Figure 2B).672 K Xu and PJ Thornalley 
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The general caspase inhibitor Z-VAD-fmk (50 mM) did not inhibit
the activation of JNK; in fact, it increased slightly the intensity of
the blot, suggesting that it may have further increased JNK
activity. Curcumin (50 mM), however, inhibited the activation of
JNK (Figure 2C). 
The tyrosine phosphorylation status of cytosolic proteins
changed during PEITC-induced apoptosis was investigated. In
cytosolic extracts of HL60 cells, two major protein bands of mo-
lecular mass ca. 40 kDa and 65 kDa were detected (Figure 1B,
lane 1). When HL60 cells were incubated with 10 mM PEITC for 6
h, cytosolic extracts indicated the appearance of two new phospho-
protein bands of molecular mass 18 kDa and 45 kDa (Figure 1B,
lane 2). This tyrosine phosphorylation was prevented by the addi-
tion of 15 mM GSH (Figure 1B, lanes 3 and 4). 
Their formation was prevented by addition of 15 mM GSH. The
effect of PEITC on the protein tyrosine phosphatase (PTP) activity
of HL60 cells was studied. After 3 h, when the maximum binding
of PEITC to cell protein occurred (Xu and Thornalley, 2001), 
the PTP activity was: control 2.12 ± 0.26, and + 10 mM PEITC
2.10 ± 0.11 (n = 3; P > 0.05). 
DISCUSSION 
When HL60 cells were incubated with PEITC in vitro, caspase-8
and caspase-3 were activated (Xu and Thornalley, 2000). Caspase-
8 and caspase-3 cleave BID protein to 3 fragments, p15, p13 and
p11 fragments (Bossy-Wetzel and Green, 1999; Gross 
et al, 1999). This was found in PEITC-induced apoptosis of HL60
cells herein. p15 interacts with Bcl-XL in mitochondria, leading to
cytochrome c release and loss of mitochondrial membrane poten-
tial (Li et al, 1998). A high concentration of GSH (15 mM) added
to the extracellular medium prevented BID cleavage (this study)
and apoptosis (Xu and Thornalley, 2001). Glutathione prevented
the binding of PEITC to cells, probably by non-enzymatic forma-
tion of PETC-SG extracellularly. This keeps the PEITC concentra-
tion below cytotoxic levels. PETC-SG fragments to reform PEITC
but there is a continuous slow hydrolysis of PEITC to inactive
products that diminishes its pharmacological activity (Xu and
Thornalley, 2000). 
Both PEITC and AITC activated JNK in HL60 cells. JNK activ-
ation was mediated by MEKK1 (Yu et al, 1996; Chen et al, 1998).
The strongest activation of JNK by PEITC occurred after 3 h when
the concentration of cellular adducts of PEITC was maximal, the
cellular GSH concentration was at a minimum and commitment 
to apoptosis occurred (Xu and Thornalley, 2000, 2001). Exo-
genous GSH prevented JNK but Z-VAD-fmk did not despite being
an efficient inhibitor of caspase-3 and caspase-8 and, indeed, 
an efficient inhibitor of PEITC-induced apoptosis (Xu and
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Figure 1 (A) Cleavage of cytosolic BID protein during PEITC-induced
apoptosis of HL60 cells. BID protein (p22) and cleavage fragments (p11, p13
and p15) were detected by immunoblotting with anti-BID polyclonal antibody.
Samples: cytosolic extracts of HL60 cells (1 ´ 107) incubated for 6 h with and
without additives at an initial cell density of 5 ´ 105 ml–1. The blot shown was
typical of 3 independent experiments. Key: lane 1, control; lane 2, PEITC
(10 mM); lane 3, GSH (15 mM); and lane 4, PEITC (10 mM) + GSH (15 mM).
(B) Tyrosine phosphorylation of 18 and 45 kDa proteins during PEITC-
induced apoptosis HL60 cells. Phosphotyrosine residues were detected by
immunoblotting with monoclonal anti-phosphotyrosine IgG antibody.
Samples: cytosolic extracts of HL60 cells (1 ´ 107) incubated for 6 h with and
without additives at an initial cell density of 5 ´ 105 ml–1. The blot shown was
typical of 3 independent experiments. Key: lane 1, control; lane 2, PEITC 
(10 mM); lane 3, GSH (15 mM); and lane 4, PEITC (10 mM) + GSH 
(15 mM) 
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Figure 2 Activation of JNK in HL60 cells during isothiocyanate-induced
apoptosis and prevention by glutathione and curcumin but not by Z-VAD-fmk.
HL60 cells (5 ´ 105 ml–1; 1 ´ 107) were incubated for 3 h with and without
additives. Cell lysates were prepared, and JNK activity determined by a 
c-Jun fusion protein phosphorylation assay. Key: (A) Time course of JNK
activation by PEITC, (B) prevention of PEITC and AITC-induced JNK
activation by GSH, and (C) effect of Z-VAD-fmk and curcuminBID, tyrosine phosphorylation and JNK by dietary isothiocyanates 673
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Thornalley, 2000). This excludes a role for caspases in the activ-
ation of MEKK1 (Cardone et al, 1997) in PEITC-induced apop-
tosis. The signalling upstream of MEKK1 is unknown. Curcumin
suppressed the activation of JNK by PEITC and delayed but did
not prevent the development of apoptosis (Xu and Thornalley,
2001). The role of JNK in apoptosis may be to potentiate cell death
– JNK activation without executioner caspases did not induce
apoptosis. JNK signalling increases the expression of fas ligand
for increased agonism at the fas cell death receptor (Faris 
et al, 1998) and counters the anti-apoptotic activity of Bcl-xL in
mitochondria (Kharbanda et al, 2000). 
A critical role for tyrosine phosphorylation in signal transduc-
tion in apoptosis has been proposed (Chen et al, 1999), including
apoptosis of HL60 cells (Lumelsky and Schwartz, 1996).
Inhibition of protein tyrosine phosphatases has been shown to
potentiate apoptosis (Chen et al, 1999) although the fas-associated
protein tyrosine phosphatase (FAP-1) that is influential in coun-
tering fas-mediated apoptosis (Li et al, 2000) was not highly
expressed in HL60 cells (Komada et al, 1997). Protein tyrosine
phosphorylation was an early event in PEITC-induced apoptosis
of HL60 cells. Protein tyrosine phosphatases may be susceptible to
inhibition by isothiocyanates by modification of their active site
cysteinyl thiol (Denu and Tanner, 1998). We were unable,
however, to demonstrate an effect of PEITC on protein tyrosine
phosphatases. Hence, increased protein tyrosine kinase activity is
implicated in the increased protein tyrosine phosphorylation in
isothiocyanate-induced apoptosis. 
PEITC is in phase I clinical trial for the chemoprevention of
cancer. It may eventually find use in the prevention of primary and
secondary tumours in vivo. The induction of tumour apoptosis
contributes to these chemopreventive effects (Nishikawa et al,
1997; Samaha et al, 1997; Sugie et al, 1999). 
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